These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16038123

  • 1. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract] [Full Text] [Related]

  • 2. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan 31; 47(1201):12. PubMed ID: 15706700
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R, Koller WC.
    Adv Neurol; 1996 Jan 31; 69():487-91. PubMed ID: 8615169
    [No Abstract] [Full Text] [Related]

  • 4. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH, Odin P.
    Curr Med Res Opin; 2011 May 31; 27(5):907-19. PubMed ID: 21351823
    [Abstract] [Full Text] [Related]

  • 5. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB, Suchowersky O, Purves S, Calne S, Calne DB.
    Clin Neuropharmacol; 1986 May 31; 9(2):196-9. PubMed ID: 3708604
    [No Abstract] [Full Text] [Related]

  • 6. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 7. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings.
    Neurology; 1989 Nov 25; 39(11 Suppl 2):1-106. PubMed ID: 2586761
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD, Ismail HA, Frank C.
    Can Fam Physician; 2001 Jan 25; 47():112-3. PubMed ID: 11212422
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2009 Jan 25; 165(8-9):718-27. PubMed ID: 19150100
    [Abstract] [Full Text] [Related]

  • 12. Continuous levodopa infusion is better—for now.
    Nutt JG.
    Mov Disord; 2015 Apr 25; 30(4):443-5. PubMed ID: 25757898
    [No Abstract] [Full Text] [Related]

  • 13. Recent advances in the treatment of Parkinson's disease.
    Martocci RJ.
    J Am Osteopath Assoc; 1975 Apr 25; 74(8):730-41. PubMed ID: 1092751
    [No Abstract] [Full Text] [Related]

  • 14. Necessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients.
    Klostermann F, Bojarski C, Marzinzik F, Maier A, Schindlbeck KA, Ehlen F.
    Mov Disord; 2017 Feb 25; 32(2):300-301. PubMed ID: 27859611
    [No Abstract] [Full Text] [Related]

  • 15. [Drug therapy of Parkinson's disease].
    Zhou XD.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 25; 18(4):193-6. PubMed ID: 4075905
    [No Abstract] [Full Text] [Related]

  • 16. Levodopa-associated hemifacial dystonia.
    Mark MH, Sage JI.
    Mov Disord; 1991 Aug 25; 6(4):383. PubMed ID: 1758464
    [No Abstract] [Full Text] [Related]

  • 17. [Continuous treatment with levodopa of Parkinson disease].
    Lundqvist C, Nystedt T, Reiertsen O, Grotli R, Beiske AG.
    Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2638-40. PubMed ID: 16215609
    [Abstract] [Full Text] [Related]

  • 18. Knotting of Duodopa® duodenal infusion system.
    del-Hoyo-Francisco J, Bustamante-Balén M, Martínez-Torres I, Barrios-Barrios A, Satorres-Paniagua C, Pons-Beltrán V.
    Rev Esp Enferm Dig; 2015 May 06; 107(5):323-4. PubMed ID: 25952811
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage.
    Munro Neville A, Parsons RW, Askmark H, Nyholm D.
    Parkinsonism Relat Disord; 2012 Jun 06; 18(5):686-7. PubMed ID: 22197121
    [No Abstract] [Full Text] [Related]

  • 20. [Current possibilities of quality of life improvement in the late stages of Parkinson's disease].
    Titova NV, Katunina EA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Jun 06; 115(3):94-100. PubMed ID: 26171484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.